• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

带或不带肉丸的汤:营养因素对 MIC、杀菌率和生长率的影响。

Soup with or without meatballs: Impact of nutritional factors on the MIC, kill-rates and growth-rates.

机构信息

Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Erasmus University Medical Center, Rotterdam, the Netherlands.

出版信息

Eur J Pharm Sci. 2018 Dec 1;125:23-27. doi: 10.1016/j.ejps.2018.09.008. Epub 2018 Sep 12.

DOI:10.1016/j.ejps.2018.09.008
PMID:30218696
Abstract

BACKGROUND

The Minimum Inhibitory Concentration (MIC) is a reference value for susceptibility testing of bacteria. However, the MIC is a net result of growth and killing after a certain duration of exposure under standardized favourable in vitro conditions. Killing and growth characteristics of a drug may yield more information on its activity and help to explain discrepancies between efficacy observed in vitro and in vivo.

METHODS

The MIC of meropenem was determined for P. aeruginosa ATCC 27853 both by microdilution and the E-test in dilutions of Mueller Hinton (MH) broth from 100% to 1%. Time-kill curves were obtained for twofold dilutions of meropenem. Growth rates and kill rates at each concentration and dilution were obtained by linear regression. The Hill equation was fit to the kill rates vs concentrations.

RESULTS

Growths rates decreased log linearly from 0.63/h at 100% to 0.29/h at 6% MH. Over the 100-6% MH dilution range, there was a log-linear decrease of the MIC of meropenem of both the E-test and microdilution. The EC50s decreased from 0.29 mg/L to 0.07 mg/L, which is in agreement with the MIC results. There was a log-linear relationship between MIC and EC50 for the various dilutions MH.

CONCLUSIONS

The availability of nutritional factors is related to the MIC, and a lower availability is related to both a lower growth rate and higher kill rate. Since nutritional factors are less abundantly available in vivo as compared to in vitro, this should be taken into account when translating in vitro to in vivo pharmacodynamics.

摘要

背景

最低抑菌浓度(MIC)是用于细菌药敏试验的参考值。然而,MIC 是在标准化有利的体外条件下暴露一定时间后生长和杀灭的净结果。药物的杀菌和生长特性可以提供更多关于其活性的信息,并有助于解释体外和体内观察到的疗效差异。

方法

采用微量稀释法和 E 试验,在 Mueller Hinton(MH)肉汤中从 100%到 1%进行稀释,测定铜绿假单胞菌 ATCC 27853 的美罗培南 MIC。获得美罗培南两倍稀释液的时间杀菌曲线。通过线性回归获得每个浓度和稀释度的生长率和杀灭率。用 Hill 方程拟合杀菌率与浓度的关系。

结果

生长率从 100%的 0.63/h 对数线性下降到 6% MH 的 0.29/h。在 100-6% MH 稀释范围内,E 试验和微量稀释法的美罗培南 MIC 均呈对数线性下降。EC50 从 0.29mg/L 下降到 0.07mg/L,与 MIC 结果一致。在各种 MH 稀释度下,MIC 和 EC50 之间存在对数线性关系。

结论

营养因子的可获得性与 MIC 有关,营养因子的可获得性越低,生长率越低,杀灭率越高。由于与体外相比,体内的营养因子的可获得性较低,因此在将体外药效学转化为体内药效学时应考虑这一点。

相似文献

1
Soup with or without meatballs: Impact of nutritional factors on the MIC, kill-rates and growth-rates.带或不带肉丸的汤:营养因素对 MIC、杀菌率和生长率的影响。
Eur J Pharm Sci. 2018 Dec 1;125:23-27. doi: 10.1016/j.ejps.2018.09.008. Epub 2018 Sep 12.
2
Modelling time-kill studies to discern the pharmacodynamics of meropenem.构建时间-杀菌研究模型以识别美罗培南的药效学。
J Antimicrob Chemother. 2005 May;55(5):699-706. doi: 10.1093/jac/dki086. Epub 2005 Mar 16.
3
Comparative in vitro pharmacodynamics of imipenem and meropenem against Pseudomonas aeruginosa.亚胺培南和美罗培南对铜绿假单胞菌的体外药效学比较
Antimicrob Agents Chemother. 1996 Apr;40(4):904-8. doi: 10.1128/AAC.40.4.904.
4
Pharmacokinetic/pharmacodynamic modelling of antibacterials in vitro and in vivo using bacterial growth and kill kinetics: the minimum inhibitory concentration versus stationary concentration.利用细菌生长和杀灭动力学进行抗菌药物体外和体内药代动力学/药效学建模:最低抑菌浓度与稳态浓度的关系
Clin Pharmacokinet. 2005;44(2):201-10. doi: 10.2165/00003088-200544020-00005.
5
Impact of erythrocytes on bacterial growth and antimicrobial activity of selected antibiotics.红细胞对选定抗生素的细菌生长和抗菌活性的影响。
Eur J Clin Microbiol Infect Dis. 2019 Mar;38(3):485-495. doi: 10.1007/s10096-018-03452-4. Epub 2019 Jan 28.
6
[Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates].[VITEK 2系统对临床分离铜绿假单胞菌美罗培南药敏试验的性能评估]
Mikrobiyol Bul. 2011 Jul;45(3):411-21.
7
Antibacterial activity of achievable epithelial lining fluid exposures of Amikacin Inhale with or without meropenem.阿米卡星吸入剂(无论有无美罗培南)可达到的上皮衬液暴露量的抗菌活性。
J Antimicrob Chemother. 2016 Feb;71(2):428-37. doi: 10.1093/jac/dkv370. Epub 2015 Nov 10.
8
Investigations on the bactericidal activity of fosfomycin using the membrane filter-agar dilution method and the time-kill technique.采用滤膜琼脂稀释法和时间杀菌技术对磷霉素的杀菌活性进行研究。
Zentralbl Bakteriol Mikrobiol Hyg A. 1985 Oct;260(2):260-72. doi: 10.1016/s0176-6724(85)80123-1.
9
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.非传统抗菌药物单独或联合使用对从重症监护病房分离出的多重耐药铜绿假单胞菌和鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7.
10
Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa.优化美罗培南最低浓度/MIC比值以抑制铜绿假单胞菌的体外耐药性。
Antimicrob Agents Chemother. 2005 Dec;49(12):4920-7. doi: 10.1128/AAC.49.12.4920-4927.2005.

引用本文的文献

1
Antibacterial compounds against non-growing and intracellular bacteria.针对非生长型和细胞内细菌的抗菌化合物。
NPJ Antimicrob Resist. 2025 Apr 11;3(1):25. doi: 10.1038/s44259-025-00097-0.
2
PKPD Modeling of the Inoculum Effect of on Polymyxin B .多粘菌素B接种量效应的药代动力学-药效学建模
Front Pharmacol. 2022 Mar 16;13:842921. doi: 10.3389/fphar.2022.842921. eCollection 2022.
3
Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro model.口服磷霉素对体外动态膀胱感染肺炎克雷伯菌的活性。
J Antimicrob Chemother. 2022 Apr 27;77(5):1324-1333. doi: 10.1093/jac/dkac045.
4
Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model.不同哌拉西林-他唑巴坦给药方案在动态感染模型中对其与妥布霉素联合应用治疗重症患者药代动力学协同作用的影响。
Antibiotics (Basel). 2022 Jan 13;11(1):101. doi: 10.3390/antibiotics11010101.
5
Evaluation of Metallo-β-Lactamase Susceptibility Testing in a Physiologic Medium.在生理介质中进行金属β-内酰胺酶敏感性测试的评估。
Microbiol Spectr. 2021 Nov 24;9(3):e0167021. doi: 10.1128/Spectrum.01670-21.
6
Limitations of Antibiotic MIC-Based PK-PD Metrics: Looking Back to Move Forward.基于抗生素最低抑菌浓度的药代动力学-药效学指标的局限性:回顾过去,展望未来。
Front Pharmacol. 2021 Oct 29;12:770518. doi: 10.3389/fphar.2021.770518. eCollection 2021.
7
ResFinder 4.0 for predictions of phenotypes from genotypes.ResFinder 4.0 用于基因型到表型的预测。
J Antimicrob Chemother. 2020 Dec 1;75(12):3491-3500. doi: 10.1093/jac/dkaa345.
8
Oral Fosfomycin Treatment for Enterococcal Urinary Tract Infections in a Dynamic Model.动态模型中口服磷霉素治疗肠球菌尿路感染。
Antimicrob Agents Chemother. 2020 May 21;64(6). doi: 10.1128/AAC.00342-20.
9
Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.危重症儿童抗生素的药代动力学与目标达成情况:当前文献的系统评价
Clin Pharmacokinet. 2020 Feb;59(2):173-205. doi: 10.1007/s40262-019-00813-w.